The Affordable Care Act has helped reduce uninsurance, but has replaced it with underinsurance. Michael E. Chernew, PhD, the Leonard D. Schaeffer Professor of Health Care Policy and director of the Healthcare Markets and Regulation Lab in the Department of Health Care Policy at Harvard Medical School, explains how to address this new problem
The Affordable Care Act has helped reduce uninsurance, but has replaced it with underinsurance. Michael E. Chernew, PhD, the Leonard D. Schaeffer Professor of Health Care Policy and director of the Healthcare Markets and Regulation Lab in the Department of Health Care Policy at Harvard Medical School, explains how to address this new problem
Transcript
What are the challenges of underinsurance in the United States and what strategies can be used to reduce it?
So we've struggled a lot with uninsurance in the United States and the Affordable Care Act was meant to address that and it has made great stride, although it has certainly not eliminated uninsurance in the United States, but in many ways it has replaced uninsurance with underinsurance, which is a situation where people have insurance but there are considerable cost sharing. Even the silver plan in the Affordable Care Act, which is the benchmark plan for people on the exchanges, has what is known as a 70% actuarial value, which means the health plan pays 70% of the medical expenses. Leaving the beneficiary to pay, on average, 30%. That's an awful lot of cost sharing for people who are typically on the lower end of the income distribution.
The challenge that we face with that situation is, it's easy to want to fill all the cost sharing holes, but that comes at a fiscal consequence. So one strategy to address the underinsurance problem is to try and target your efforts toward those high-value services. And a number of us have been thinking through different ways to work with exchanges and other entities that are designing plans to figure out how you can build a plan that has a 70% actuarial value, but has better coverage for the most important services.
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More
Commonwealth Fund Report Details Pervasive Racial and Ethnic Disparities in US Health Care, Outcomes
April 18th 2024Using 25 health system performance indicators, the Commonwealth Fund 2024 State Health Disparities Report evaluated racial and ethnic disparities in health care and health outcomes both within and across US states and highlighted the urgent need for equitable health care policies and practices in the US.
Read More